Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
The Journal of Biological Chemistry
|
March 29, 2001
The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes
J E Tan, S C Wong, S K Gan, et al.
International Immunology
|
March 4, 2000
B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice
S Xu, J E Tan, E P Wong, et al.
Neurology
|
March 26, 2003
Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese
D K Y Chan, M K P Lam, R Wong, et al.
Frontiers in Microbiology
|
March 31, 2018
Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection
Janice K P Lam, K F Hui, Raymond J Ning, et al.
Cell
|
March 6, 1992
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
Y Shinkai, G Rathbun, K P Lam, et al.
Frontiers in Immunology
|
July 7, 2020
Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56<sup>dim</sup>NKG2A<sup>+</sup>KIR<sup>-</sup> NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder
Janice K P Lam, Tarik Azzi, K F Hui, et al.
Cell Death & Disease
|
February 12, 2016
Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis
J Huo, Y Ma, J-J Liu, et al.
Plos Pathogens
|
December 21, 2020
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
Nicole Caduff, Donal McHugh, Anita Murer, et al.
Plos Pathogens
|
April 7, 2020
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
Nicole Caduff, Donal McHugh, Anita Murer, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
The Journal of Biological Chemistry
|
March 29, 2001
The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes
J E Tan, S C Wong, S K Gan, et al.
International Immunology
|
March 4, 2000
B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice
S Xu, J E Tan, E P Wong, et al.
Neurology
|
March 26, 2003
Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese
D K Y Chan, M K P Lam, R Wong, et al.
Frontiers in Microbiology
|
March 31, 2018
Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection
Janice K P Lam, K F Hui, Raymond J Ning, et al.
Cell
|
March 6, 1992
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
Y Shinkai, G Rathbun, K P Lam, et al.
Frontiers in Immunology
|
July 7, 2020
Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56<sup>dim</sup>NKG2A<sup>+</sup>KIR<sup>-</sup> NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder
Janice K P Lam, Tarik Azzi, K F Hui, et al.
Cell Death & Disease
|
February 12, 2016
Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis
J Huo, Y Ma, J-J Liu, et al.
Plos Pathogens
|
December 21, 2020
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
Nicole Caduff, Donal McHugh, Anita Murer, et al.
Plos Pathogens
|
April 7, 2020
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
Nicole Caduff, Donal McHugh, Anita Murer, et al.
Page
of 3